MERIDIAN BIOSCIENCE, INC. Business Combination, Acquisition Related Costs
MERIDIAN BIOSCIENCE, INC. reported Business Combination, Acquisition Related Costs of $1.19 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2023-02-09
- MERIDIAN BIOSCIENCE, INC. business combination, acquisition related costs for the quarter ending 2022-12-31 was $1.19M.
- MERIDIAN BIOSCIENCE, INC. business combination, acquisition related costs for the quarter ending 2022-09-30 was $2.65M, a 2775.00% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. business combination, acquisition related costs for the quarter ending 2022-06-30 was $4.23M, a 1309.00% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. business combination, acquisition related costs for the quarter ending 2022-03-31 was $68.00K.
- MERIDIAN BIOSCIENCE, INC. business combination, acquisition related costs for fiscal 2022 was $6.94M, a 1670.41% increase from fiscal 2021.
- MERIDIAN BIOSCIENCE, INC. business combination, acquisition related costs for fiscal 2021 was $392.00K, a 89.92% decline from fiscal 2020.
- MERIDIAN BIOSCIENCE, INC. business combination, acquisition related costs for fiscal 2020 was $3.89M, a 115.15% increase from fiscal 2019.
- MERIDIAN BIOSCIENCE, INC. business combination, acquisition related costs for fiscal 2019 was $1.81M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $1.19M 10-Q · filed 2023-02-09 | $3.83M derived: sum of 2 quarters · filed 2023-02-09 | $8.06M derived: sum of 3 quarters · filed 2023-02-09 | $8.13M derived: sum of 4 quarters · filed 2023-02-09 |
| 2022-09-30 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $6.87M derived: sum of 2 quarters · filed 2022-11-22 | $6.94M derived: sum of 3 quarters · filed 2022-11-22 | $6.94M 10-K · filed 2022-11-22 |
| 2022-06-30 | $4.23M 10-Q · filed 2022-08-05 | $4.29M derived: sum of 2 quarters · filed 2022-08-05 | $4.29M 10-Q · filed 2022-08-05 | $4.39M derived: sum of 4 quarters · filed 2023-02-09 |
| 2022-03-31 | $68.00K 10-Q · filed 2022-05-06 | $68.00K 10-Q · filed 2022-05-06 | $160.00K derived: sum of 3 quarters · filed 2023-02-09 | $460.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-09 | $92.00K derived: sum of 2 quarters · filed 2023-02-09 | $392.00K derived: sum of 3 quarters · filed 2023-02-09 | $392.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $392.00K derived: sum of 2 quarters · filed 2022-11-22 | $392.00K derived: sum of 3 quarters · filed 2022-11-22 | $392.00K 10-K · filed 2022-11-22 |
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-05 | $300.00K derived: sum of 2 quarters · filed 2022-08-05 | $300.00K 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | $0.00 10-Q · filed 2022-05-06 | ||
| 2020-09-30 | $462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $2.10M derived: sum of 2 quarters · filed 2022-11-22 | $3.89M derived: sum of 3 quarters · filed 2022-11-22 | $3.89M 10-K · filed 2022-11-22 |
| 2020-06-30 | $1.64M 10-Q · filed 2021-08-06 | $3.43M derived: sum of 2 quarters · filed 2021-08-06 | $3.43M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $1.79M 10-Q · filed 2021-05-07 | $1.79M 10-Q · filed 2021-05-07 | ||
| 2019-09-30 | $363.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-23 | $836.00K derived: sum of 2 quarters · filed 2021-11-23 | $1.72M derived: sum of 3 quarters · filed 2021-11-23 | $1.81M 10-K · filed 2021-11-23 |
| 2019-06-30 | $473.00K 10-Q · filed 2020-08-07 | $1.36M derived: sum of 2 quarters · filed 2020-08-07 | $1.45M 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $885.00K 10-Q · filed 2020-05-08 | $972.00K 10-Q · filed 2020-05-08 |